Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > T-Vec

<< Previous

Bullboard Posts

Next >>

Comment by Lesalpes29on Mar 05, 2023 8:43pm

101 Views

Post# 35320424

RE:RE:T-Vec

Speculation only... interest is high or not? Biding war or not... not enough good results to create a war actually! Always pushed an other year... an other six months... can we believe them... lot of speculation but it's still weak. GL

<< Previous

Bullboard Posts

Next >>

High-grade gold potential in the world’s best mining jurisdiction